CORP BRIEF: T7 Global, PR1MA, Prestige Biopharma and NS Corp

Posted on

THE MALAYSIAN RESERVE. 30TH MARCH:

T7 Global secures 3-year contract from Petronas 

T7 GLOBAL Bhd’s subsidiary, T7 Intelligent Resources Sdn Bhd (T7IR), had secured a three-year contract from Petronas Group of Cos for the provision of third-party professional and support services. T7IR is principally involved in recruitment and people solutions for the energy, information communication technology (ICT), banking, financial technology and construction industries. Its vision is to further promote the hiring and development of Malaysian talent in the ICT industry and digital space, as well as within the oil and gas and new energy industry. T7IR was formerly a 51% subsidiary of the company until February 2021, when the company took full control of T7IR.

PR1MA to propose QIA on affordable housing 

PR1MA Malaysia Corp (PR1MA) is hoping to attract the Qatar Investment Authority (QIA) into a strategic relationship to build affordable homes in Malaysia. According to a release by PR1MA yesterday, the QIA expressed its intention to explore cooperation opportunities with PR1MA, including the development of the best sustainable business model in order to support the work of contractors working with PR1MA to carry out the mandate to build 100,000 units of high-quality affordable housing in line with the United Nations’ Sustainable Development Goals. To date, all PRIMA houses are priced between RM100,000 and RM400,000 and are open to Malaysian citizens above the age of 21, earning a combined monthly income of RM2,500-RM15,000.

Prestige Biopharma, Vaxine enter MoU on Covid-19 vaccine 

PRESTIGE Biopharma Ltd and Vaxine Pte Ltd have entered into a memorandum of understanding (MoU) to collaborate on the supply of Vaxine’s Covid-19 Vaccine, Covax-19® (also known as Spikogen®) and on the co-development of Covid-19/influenza combo vaccine. The MoU will bring together Prestige’s global scale vaccine manufacturing capacity and research expertise with Vaxine’s innovative vaccine technologies including its vaccines against Covid-19, seasonal and pandemic influenza, Hepatitis B, Japanese encephalitis, dengue, malaria, allergy and cancer.

NS Corp, Havelsan JV on NS Aerospace Valley 

NEGRI Sembilan’s investment arm NS Corp has inked a memorandum of collaboration (MoC) with Turkey-based software and hardware provider Havelsan for the development of NS Aerospace Valley and Unmanned Vehicle Valley in the state.